The combination of estradiol valerate and<unk>  is used in menopausal hormone therapy to treat menopausal symptoms in peri- and postmenopausal women. Estradiol valerate serves as an estrogen in the preparation, while<unk>  is intended to serve as a weak androgen. It is thought that the inclusion of<unk>  in the formulation may provide additional psychotropic benefits. Available forms<unk>  is available only as a combination formulation of 4 mg estradiol valerate and 200 mg<unk>  in oil for depot intramuscular injection.
Prasterone enanthate
Prasterone sulfate
Oxabolone cipionate
Bolandiol dipropionate
Etynodiol diacetate
Methestrol dipropionate
Gestonorone caproate
Oxyprothepin decanoate